Centrica plcLSE: CNA

Centrica: Director/PDMR Shareholding

· Issued by Centrica plc via RNS

Summary by 6ix AI

Centrica plc said executive directors Christopher O'Shea and Russell O'Brien acquired Centrica ordinary shares on November 10, 2026 under the company's Share Incentive Plan, bought on their behalf by Equiniti Share Plan Trustees Limited.

Key details

  • Christopher O'Shea acquired 119 shares at an average of £1.538 per share, totalling £183.03: 97 partnership shares (shares bought with the employee's own money) at £1.54095 and 22 matching shares (shares the company adds) at £1.52516666.
  • Russell O'Brien acquired 120 shares at an average of £1.538 per share, totalling £184.57: 98 partnership shares at £1.54095 and 22 matching shares at £1.52516666.
  • The partnership shares were bought on the London Stock Exchange and the matching shares were acquired outside a trading venue.

6ix AI wrote this summary from the release below and checked it against the release.

Centrica PLC
11 November 2026

Centrica plc (the ‘Company’)

11 November 2026

Notification of Transactions of Directors

The Company was notified by Equiniti Limited, the administrators of the Company’s Share Incentive Plan (the ‘Plan’), that Centrica plc ordinary shares of 6 14/81 pence (‘Shares’) have been acquired under the Plan.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher O’Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

Identification code

Ordinary shares of 6 14/81 pence

GB00B033F229

b)

Nature of the transaction

Acquisition of Partnership Shares and Matching Shares on behalf of a PDMR by Equiniti Share Plan Trustees Limited under the Company’s Share Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.54095

97 (Partnership shares)

£1.52516666

22 (Matching shares)

d)

Aggregated information

Aggregated volume

- Price

- Total

119 Shares

£1.538 per Share

£183.03

e)

Date of the transaction

10 November 2026

f)

Place of the transaction

London Stock Exchange (Partnership shares)

Outside a trading venue (Matching shares)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russell O’Brien

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

Identification code

Ordinary shares of 6 14/81 pence

GB00B033F229

b)

Nature of the transaction

Acquisition of Partnership Shares and Matching Shares on behalf of a PDMR by Equiniti Share Plan Trustees Limited under the Company’s Share Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.54095

98 (Partnership shares)

£1.52516666

22 (Matching shares)

d)

Aggregated information

Aggregated volume

- Price

- Total

120 Shares

£1.538 per Share

£184.57

e)

Date of the transaction

10 November 2026

f)

Place of the transaction

London Stock Exchange (Partnership shares)

Outside a trading venue (Matching shares)

Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Centrica plc on 6ix

Story so far

Earlier from Centrica

Later from Centrica

All Centrica news releases